Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
166.05
+1.39 (+0.84%)
Streaming Delayed Price
Updated: 3:33 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about AbbVie
< Previous
1
2
3
4
5
6
7
Next >
Genmab and AbbVie Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) From Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL)
April 13, 2022
From
Genmab A/S
Via
Business Wire
Investor Action Reminder: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm
April 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
April 13, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
AbbVie Inc. (ABBV) Climbs to Annual-High Share Price
March 15, 2022
Via
Investor Brand Network
AbbVie Inc. (ABBV) Climbs to Annual-High Share Price
March 15, 2022
Via
Investor Brand Network
AbbVie Inc. (ABBV): The Winning Streak Continues
February 15, 2022
Via
Investor Brand Network
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
April 13, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
ABBVIE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against AbbVie, Inc. and Encourages Investors to Contact the Firm
April 12, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
April 12, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
AbbVie Inc. (ABBV): The Winning Streak Continues
February 15, 2022
Via
Investor Brand Network
AbbVie Inc. (ABBV) Climbs to Annual-High Share Price
February 04, 2022
Via
Investor Brand Network
AbbVie Inc. (ABBV) Climbs to Annual-High Share Price
February 04, 2022
Via
Investor Brand Network
Shareholder Action Notice: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm
April 12, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages AbbVie Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ABBV
April 12, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies AbbVie, Inc. (ABBV) Investors of Class Action and Encourages Investors to Contact the Firm
April 12, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Shareholder Action Alert: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm
April 11, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Watch for Continued Gains in Shares of AbbVie Inc. (ABBV)
February 02, 2022
Via
Investor Brand Network
ROSEN, A TOP RANKED FIRM, Encourages AbbVie Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action ABBV
April 10, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Investor Action Reminder: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm
April 08, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against AbbVie Inc. (ABBV)
April 08, 2022
From
Robbins LLP
Via
Business Wire
ABBV EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Files Investor Securities Fraud Class Action Lawsuit against AbbVie, Inc. (ABBV)
April 08, 2022
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm
April 07, 2022
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm
April 06, 2022
From
The Schall Law Firm
Via
Business Wire
EQUITY NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages AbbVie Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ABBV
April 06, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
Resorts World Las Vegas Secures First-of-its-Kind Agreement With Allergan Aesthetics
April 04, 2022
From
AEG
Via
Business Wire
Top Ideas in the Small Cap Biotech Space (LEXTF, ABBV, SAVA, SNDL, RETA, PAHC)
January 24, 2022
Via
AB Newswire
New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024
January 10, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 10, 2021 – USA News Group – Nearly 10% of the estimated ~1.9 million new cancer cases in the USA will be diagnosed as...
Via
FinancialNewsMedia
2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, PSTV, IMMX, GNPX, NRBO)
January 06, 2022
Via
AB Newswire
Global Alzheimer’s Disease Therapeutics Market Projected To Generate Revenue Of $9.97 Billion By 2028
January 04, 2022
Palm Beach, FL –January 4, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease is a degenerative, progressive ailment that attacks the brain’s nerve cells, resulting in memory loss,...
Via
FinancialNewsMedia
Exposures
COVID-19
AbbVie Inc. (ABBV) Looks to Continue to Trade Above its Annual-High Share Price Today
December 27, 2021
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.